ALPS Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,257
| Closed | -$89.7K | – | 1037 |
|
|
2025
Q1 | $89.7K | Sell |
16,257
-880
| -5% | -$4.86K | ﹤0.01% | 981 |
|
|
2024
Q4 | $98.5K | Buy |
17,137
+1,099
| +7% | +$6.32K | ﹤0.01% | 986 |
|
|
2024
Q3 | $166K | Sell |
16,038
-484
| -3% | -$5.01K | ﹤0.01% | 983 |
|
|
2024
Q2 | $214K | Buy |
16,522
+1,602
| +11% | +$20.8K | ﹤0.01% | 949 |
|
|
2024
Q1 | $261K | Buy |
14,920
+319
| +2% | +$5.57K | ﹤0.01% | 939 |
|
|
2023
Q4 | $137K | Sell |
14,601
-896
| -6% | -$8.43K | ﹤0.01% | 950 |
|
|
2023
Q3 | $173K | Buy |
15,497
+21
| +0.1% | +$235 | ﹤0.01% | 963 |
|
|
2023
Q2 | $331K | Buy |
15,476
+1,717
| +12% | +$36.7K | ﹤0.01% | 785 |
|
|
2023
Q1 | $556K | Sell |
13,759
-320
| -2% | -$12.9K | ﹤0.01% | 578 |
|
|
2022
Q4 | $655K | Buy |
14,079
+2,794
| +25% | +$130K | 0.01% | 542 |
|
|
2022
Q3 | $585K | Sell |
11,285
-1,002
| -8% | -$51.9K | 0.01% | 566 |
|
|
2022
Q2 | $581K | Sell |
12,287
-8,816
| -42% | -$417K | 0.01% | 557 |
|
|
2022
Q1 | $1.5M | Sell |
21,103
-2,418
| -10% | -$172K | 0.02% | 273 |
|
|
2021
Q4 | $1.76M | Sell |
23,521
-1,250
| -5% | -$93.5K | 0.02% | 302 |
|
|
2021
Q3 | $1.41M | Sell |
24,771
-1,826
| -7% | -$104K | 0.01% | 357 |
|
|
2021
Q2 | $1.17M | Sell |
26,597
-9,727
| -27% | -$428K | 0.01% | 386 |
|
|
2021
Q1 | $1.79M | Buy |
36,324
+32
| +0.1% | +$1.58K | 0.02% | 330 |
|
|
2020
Q4 | $1.53M | Buy |
36,292
+10,697
| +42% | +$450K | 0.02% | 343 |
|
|
2020
Q3 | $1.17M | Sell |
25,595
-1,690
| -6% | -$77.4K | 0.02% | 330 |
|
|
2020
Q2 | $1.37M | Sell |
27,285
-8,581
| -24% | -$431K | 0.02% | 268 |
|
|
2020
Q1 | $1.85M | Sell |
35,866
-3,878
| -10% | -$199K | 0.03% | 221 |
|
|
2019
Q4 | $2.46M | Buy |
39,744
+470
| +1% | +$29K | 0.02% | 210 |
|
|
2019
Q3 | $2.36M | Sell |
39,274
-5,412
| -12% | -$325K | 0.02% | 199 |
|
|
2019
Q2 | $3.77M | Sell |
44,686
-6,184
| -12% | -$522K | 0.03% | 171 |
|
|
2019
Q1 | $4.86M | Buy |
50,870
+1,030
| +2% | +$98.4K | 0.03% | 167 |
|
|
2018
Q4 | $3.53M | Buy |
49,840
+10,156
| +26% | +$719K | 0.03% | 181 |
|
|
2018
Q3 | $3.39M | Buy |
39,684
+6,549
| +20% | +$560K | 0.02% | 193 |
|
|
2018
Q2 | $3.84M | Buy |
33,135
+1,872
| +6% | +$217K | 0.03% | 191 |
|
|
2018
Q1 | $2.53M | Buy |
31,263
+10,169
| +48% | +$823K | 0.02% | 190 |
|
|
2017
Q4 | $1.24M | Buy |
21,094
+2,347
| +13% | +$138K | 0.01% | 226 |
|
|
2017
Q3 | $877K | Buy |
18,747
+1,565
| +9% | +$73.2K | 0.01% | 265 |
|
|
2017
Q2 | $618K | Buy |
17,182
+806
| +5% | +$29K | ﹤0.01% | 340 |
|
|
2017
Q1 | $504K | Sell |
16,376
-19,951
| -55% | -$614K | ﹤0.01% | 407 |
|
|
2016
Q4 | $1.22M | Sell |
36,327
-5,803
| -14% | -$194K | 0.01% | 204 |
|
|
2016
Q3 | $1.12M | Buy |
42,130
+857
| +2% | +$22.8K | 0.01% | 217 |
|
|
2016
Q2 | $910K | Buy |
41,273
+4,273
| +12% | +$94.2K | 0.01% | 209 |
|
|
2016
Q1 | $1.09M | Buy |
37,000
+466
| +1% | +$13.7K | 0.01% | 186 |
|
|
2015
Q4 | $1.21M | Sell |
36,534
-4,640
| -11% | -$153K | 0.01% | 210 |
|
|
2015
Q3 | $14.9K | Buy |
41,174
+7,326
| +22% | +$2.65K | 0.02% | 186 |
|
|
2015
Q2 | $1.52M | Buy |
33,848
+9,469
| +39% | +$426K | 0.01% | 183 |
|
|
2015
Q1 | $746K | Buy |
24,379
+10,805
| +80% | +$331K | 0.01% | 200 |
|
|
2014
Q4 | $690K | Sell |
13,574
-1,326
| -9% | -$67.4K | 0.01% | 192 |
|
|
2014
Q3 | $590K | Buy |
+14,900
| New | +$590K | ﹤0.01% | 321 |
|